Extended Data Fig. 3: Factor IX activity (FIX:C) within 6 days post gene therapy in phase 3 study.
From: Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials
FIX:C was measured with one-stage actin-FSL method.
Extended Data Fig. 3: Factor IX activity (FIX:C) within 6 days post gene therapy in phase 3 study. | Nature Medicine
